Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash flows from operating activities:
Net earnings/(loss)	$ 1,305	$ 1,326
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	715	581
Impairments and (gain)/loss on disposal of assets, net	173	(15)
Impairments and loss on sale of other investments	(20)	(2)
Share-based compensation	309	91
Provision for bad debts	47	41
Change in operating assets and liabilities, net of effects from acquisitions and divestitures:
Increase in trade receivables	(215)	(367)
Increase in inventories	(1,185)	(1,209)
Increase in accounts payable	3,013	954
Repurchases of liability-classified units	(27)	0
Other accrued liabilities and operating items, net	(673)	(527)
Net cash provided by operating activities	3,482	877
Cash flows from investing activities:
Acquisition of subsidiaries, net of cash acquired	1,967	3,855
Additions to property and equipment	(385)	(315)
Proceeds from disposal of property and equipment	31	3
Proceeds from short-term investment in time deposit	0	200
Net cash used in investing activities	(2,303)	(3,962)
Cash flows from financing activities:
Proceeds from long-term obligations, net of issuance costs	991	2,869
Reduction of long-term obligations	(637)	(434)
Payments to Noncontrolling Interests	8	7
Net tax withholding from share-based compensation	(79)	(12)
Dividends on common shares	(371)	(374)
Purchase of treasury shares, net	(1,008)	(765)
Net cash provided by/(used in) financing activities	(1,112)	1,277
Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation	(4)	1
Net increase/(decrease) in cash and equivalents	63	(1,807)
Cash and equivalents at beginning of period	3,874	5,133
Cash and equivalents at end of period	3,937	3,326
Payments to Noncontrolling Interests	(8)	(7)
Increase (decrease) in other investing items, net	(9)	(2)
Proceeds from investments	$ 27	$ 7